These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

664 related items for PubMed ID: 29445944

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.
    Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ.
    Ophthalmology; 2018 Oct; 125(10):1628-1637. PubMed ID: 29716788
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.
    Ramanathan S, Prelog K, Barnes EH, Tantsis EM, Reddel SW, Henderson AP, Vucic S, Gorman MP, Benson LA, Alper G, Riney CJ, Barnett M, Parratt JD, Hardy TA, Leventer RJ, Merheb V, Nosadini M, Fung VS, Brilot F, Dale RC.
    Mult Scler; 2016 Apr; 22(4):470-82. PubMed ID: 26163068
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies.
    Hassan MB, Stern C, Flanagan EP, Pittock SJ, Kunchok A, Foster RC, Jitprapaikulsan J, Hodge DO, Bhatti MT, Chen JJ.
    Am J Ophthalmol; 2020 Dec; 220():110-114. PubMed ID: 32707199
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study.
    Chen Q, Zhao G, Huang Y, Li Z, Sun X, Lu P, San Y, Wang M, Tian G.
    Pediatr Neurol; 2018 Jun; 83():42-49. PubMed ID: 29778487
    [Abstract] [Full Text] [Related]

  • 9. Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China.
    Zhao G, Chen Q, Huang Y, Li Z, Sun X, Lu P, Yan S, Wang M, Tian G.
    J Neurol; 2018 Jan; 265(1):33-40. PubMed ID: 29101456
    [Abstract] [Full Text] [Related]

  • 10. Postinfectious Anti-Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis and Myelitis.
    Vieira JP, Sequeira J, Brito MJ.
    J Child Neurol; 2017 Oct; 32(12):996-999. PubMed ID: 28820014
    [Abstract] [Full Text] [Related]

  • 11. Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients.
    Narayan RN, McCreary M, Conger D, Wang C, Greenberg BM.
    Mult Scler Relat Disord; 2019 Feb; 28():86-90. PubMed ID: 30576847
    [Abstract] [Full Text] [Related]

  • 12. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
    Havla J, Kümpfel T, Schinner R, Spadaro M, Schuh E, Meinl E, Hohlfeld R, Outteryck O.
    J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
    [Abstract] [Full Text] [Related]

  • 13. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
    Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ.
    Am J Ophthalmol; 2018 Nov; 195():8-15. PubMed ID: 30055153
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Optic neuropathy in positive anti-MOG antibody syndrome].
    Merabtene L, Vignal Clermont C, Deschamps R.
    J Fr Ophtalmol; 2019 Dec; 42(10):1100-1110. PubMed ID: 31732265
    [Abstract] [Full Text] [Related]

  • 16. Comparing myelin oligodendrocyte glycoprotein antibody (MOG-Ab) and non MOG-Ab associated optic neuritis: Clinical course and treatment outcome.
    Etemadifar M, Abbasi M, Salari M, Etemadifar F, Tavakoli H.
    Mult Scler Relat Disord; 2019 Jan; 27():127-130. PubMed ID: 30368225
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
    Chen JJ, Bhatti MT.
    Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis.
    Liu H, Zhou H, Wang J, Sun M, Teng D, Song H, Xu Q, Wei S.
    J Neurol Sci; 2019 Jan 15; 396():225-231. PubMed ID: 30522039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.